icon consulting

What icon consulting does

ICON plc is a Dublin-headquartered, publicly traded (NASDAQ: ICLR) global Clinical Research Organisation founded in 1990, operating 90+ locations across 50+ countries. The company delivers full-service clinical development, strategic consulting, and commercialisation services to large pharmaceutical companies, small and mid-cap biotechnology firms, medical device manufacturers, and government/public health agencies. Its service portfolio spans the entire drug development lifecycle, including early clinical and bioanalytical solutions, clinical and scientific operations, decentralised clinical trials, cardiac safety, medical imaging, specialty laboratories, manufacturing and pharmacy services, regulatory affairs consulting, market access, and real-world evidence generation.

Underpinning the service business is an integrated technology platform comprising more than 15 proprietary products, including the Orbis multi-agent AI platform, EngageAI voice-of-customer system, WorkBench, Clinical Data Studio, FIRECREST, OneView, ARCADES, FLEX ADVANTAGE, ICOMaster, ICON ORCA Safety, Evidence Platform, and NONMEM, supported by the Symphony Health real-world data partnership via HealthVerity. In 2026 ICON extended this stack through a multi-year strategic collaboration with Anthropic to embed Claude generative AI across clinical trial workflows.

ICON generates revenue through contract-based, custom-quoted CRO engagements across five streams: clinical research services, consulting services, laboratory services, manufacturing and pharmacy services, and commercial data (Symphony Health). Q2 2026 revenue was $2,063.5M with $3,120M in net new business wins (1.51 book-to-bill), and the company has contributed to over 60 FDA/EMA approved therapies in the past five years across 16+ therapeutic areas, with particular depth in oncology, cell and gene therapy, rare diseases, and biosimilars.

Name

icon consulting

Legal name

ICON plc

Website

https://iconplc.com

Company type

Public

Founded year

1990

Operating status

Operating

Short description

ICON plc is a publicly traded global Contract Research Organisation (NASDAQ: ICLR) providing full-service clinical development, consulting, and commercialisation services to pharmaceutical, biotechnology, medical device, and government clients across 50+ countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Other Scientific and Technical Consulting Services (54169), Professional, Scientific, and Technical Services (541)

SIC

Services-Health Services (8000), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Contract research organization
• Drug development services
• Clinical trial management
• Biopharmaceutical consulting

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Full-service CRO offerings including clinical operations, data management, biostatistics, medical imaging, cardiac safety solutions, and decentralized clinical trials spanning from early phase through post-marketing.
2. Consulting Services: Strategic consulting including regulatory affairs, commercial positioning, market access, health economics, and asset development consulting for drug development programs.
3. Laboratory Services: Central laboratory, specialty biomarker, bioanalytical, and biospecimen services supporting precision medicine programs across all phases of drug diagnostic co-development.
4. Manufacturing & Pharmacy Services: Rapid small batch formulation, manufacturing, labelling and distribution for clinical trials.
5. Commercial Data (Symphony Health): Health technology and business intelligence solutions through Symphony Health data for market access and commercial analytics.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

ICON plc is a global Contract Research Organisation (CRO) that provides clinical development, consulting, and commercialisation services for the life sciences industry. The company delivers end-to-end drug development support spanning early phase clinical pharmacology, bioanalytical laboratories, clinical operations, decentralized and hybrid trials, regulatory affairs consulting, real-world evidence generation, central and specialty laboratory services, manufacturing and pharmacy services, medical imaging, cardiac safety, and commercial positioning/market access consulting. ICON also develops proprietary AI-enabled technology platforms such as Orbis (multi-agent clinical trial platform) and EngageAI that are deployed alongside its services portfolio.

Product overview

ICON plc is a Clinical Research Organisation (CRO) offering a comprehensive, integrated portfolio of clinical development services. The company operates as a platform-plus-services model, combining core technology platforms (including Orbis AI platform, WorkBench, Clinical Data Studio, FIRECREST, OneView, ARCADES control tower) with extensive service offerings spanning the entire drug development lifecycle. Key service areas include: Early Clinical and Bioanalytical Solutions, Clinical & Scientific Operations, Decentralised Clinical Trials, Cardiac Safety Solutions, Site & Patient Solutions, Specialty Laboratories, Medical Imaging, Regulatory Affairs Consulting, Real World Solutions, Manufacturing & Pharmacy Services, and Biotech Sector Services. ICON also offers specialized centers for Rare Diseases and Pediatric Clinical Development. The portfolio includes AI-powered tools like Orbis (multi-agent platform) and EngageAI, alongside specialized data services through Symphony Health data partnership.

Differentiator

Problem solved

Functional benefit

Brands

• Accellacare: Patient recruitment and site services brand
• Orbis
• EngageAI
• Symphony Health
• FIRECREST
• PACE

Products and services

• Clinical & Scientific Operations Comprehensive clinical operations offering covering accelerated study start-up, biostatistics, clinical operations, clinical data science, pharmacovigilance, and medical writing for pharmaceutical and biotech sponsors running clinical development programs.
• Early Clinical and Bioanalytical Solutions Early clinical development services including clinical pharmacology studies, bioanalytical laboratory work, early phase clinical research unit operations, and specialized early phase oncology studies.
• Decentralised Clinical Trials Direct-to-patient clinical trial support and in-home clinical services that reduce patient burden and increase retention across decentralized and hybrid trial designs.
• Cardiac Safety Solutions End-to-end cardiac safety service offering spanning ECG, event monitoring, blood pressure monitoring, long-term Holter monitoring, and ECHO/MUGA studies for clinical trials.
• Specialty Laboratory Solutions Central and specialty biomarker laboratory services supporting precision medicine programs across all phases of drug-diagnostic co-development.
• Manufacturing & Pharmacy Services Rapid small-batch formulation, manufacturing, labelling and distribution services specifically designed for clinical trial supply.
• Medical Imaging Comprehensive medical imaging services for clinical trials covering collect-and-hold, imaging therapeutic expertise, rescue studies, and dedicated technology platforms.
• Regulatory Affairs Consulting Global regulatory strategy, CMC and quality services, regulatory operations, global labelling, ad/promotion, and medical device/IVD regulatory affairs consulting for drug developers.
• Real World Solutions Clinical trial tokenisation, real-world study designs, and real-world evidence generation services for clinical development and post-marketing programs.
• Site & Patient Solutions Patient-centric trial recruitment, real-world data, and global recruitment solutions including obesity programs that transform enrollment outcomes for clinical trials.
• Market Access Consulting Strategic consulting on pricing, market access, and reimbursement strategies to support commercial success of pharmaceutical products.
• Biotech Sector Services Full-service outsourcing and flexible support tailored for biotech companies covering due diligence and asset valuation, early phase development, and funding optimization.
• Blended Solutions (FSP/FSO) Bespoke, seamless solutions combining Functional Service Provider (FSP) and Full Service Outsourcing (FSO) capabilities within an interoperable infrastructure to meet unique sponsor challenges.
• Orbis AI Platform ICON's multi-agent AI platform that connects human expertise, data, and AI across the clinical trial lifecycle, enabling intelligent automation and decision support throughout clinical development.
• EngageAI AI-enhanced voice-of-the-customer feedback platform that transforms how ICON listens, responds to, and acts on customer feedback across clinical programs.
• Symphony Health Data Services Health technology and business intelligence solutions including integrated dataverse, source data, brand strategy optimization, and patient journey analytics delivered via HealthVerity.

Quantifiable outcome

• Over 60 FDA/EMA approved therapies contributed to in the last 5 years
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature18 records

Partnerships

Two partnerships are on record, tiered core.

• AnthropiccoreTechnology or Integration · 28 July 2026Multi-year collaboration to bring Claude's AI capabilities across the clinical trial lifecycle. This collaboration advances ICON's digital innovation and AI strategy, integrating Anthropic's Claude AI models to enhance clinical trial operations, data analysis, and decision-making capabilities.
• Symphony Health (HealthVerity)coreTechnology or IntegrationSymphony Health data solutions provide health technology and business intelligence solutions including integrated dataverse, market intelligence, and real-world evidence generation for commercial analytics and market access.

Scale indicators6 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• IQVIA: IQVIA is the world's largest CRO and ICON's most direct full-service competitor, offering overlapping Phase I–IV clinical operations, technology platforms (e.g., EDC, RTSM), real-world evidence, and consulting capabilities to the same pharmaceutical and biotech sponsors.
• Charles River Laboratories: Charles River competes with ICON in early-stage CRO, bioanalytical, and safety assessment services, and has expanded into broader clinical research, overlapping with ICON's early clinical and biotech client base.
• Medpace: Medpace is a mid-sized full-service CRO with a strong focus on emerging and mid-sized biotech sponsors, directly competing with ICON's biotech segment and on therapeutic expertise in oncology and rare disease.
• Syneos Health: Syneos is a full-service clinical and commercial CRO (now private after Elliott/Veritas take-private) competing directly with ICON across clinical development and commercialization services for biopharma.
• Parexel International: Parexel is a global full-service CRO (now private under EQT/Goldman) offering clinical operations, regulatory, biostatistics, and post-approval services to biopharma, overlapping with ICON's full-service delivery model.
• Fortrea: Fortrea was spun out of Labcorp to operate as a pure-play CRO, directly competing with ICON in clinical operations, clinical pharmacology, and biopharma lab services across pharma and biotech sponsors.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO competing with ICON in clinical operations, bioanalytical, and post-approval services, with a similar focus on complex therapeutic areas.

Broad incumbents

• Labcorp: Labcorp owned the Covance CRO franchise (now spun off as Fortrea) and still operates central laboratories and early-development services directly comparable to ICON's lab and early-phase offerings, competing for the same pharma diagnostics and trial work.
• Thermo Fisher Scientific (PPD): Thermo Fisher's PPD clinical research services business competes head-to-head with ICON across full-service CRO, biopharma lab services, and site management, drawing on Thermo Fisher's broader scientific instrument and life sciences resources.

Regional players

• WuXi AppTec: WuXi AppTec is a leading China-based CRO/CDMO competing with ICON in clinical and laboratory services for global biopharma sponsors, with particularly strong overlap in Asia-Pacific biotech demand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks3 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/ICONPlc
• Facebookfacebook.com/icon.plc.profile
• LinkedInlinkedin.com/company/icon-plc-2
• Instagraminstagram.com/iconplc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about icon consulting